Despite these pace-setting, quality-enhancing changes, Kaiser still looks 'foreign' to most Americans. It may be that Kaiser's time-tested model is a better 'fit' with the way care is to some extent already organized and delivered in parts of Europe. This probably explains the interest of the National Health Service (NHS) in England. However, if the past is really a prologue to the future, I predict that it will be just as difficult to 'sell' Kaiser or similar models in other parts of Europe as it has been in most of the U.S. But, why must Europeans 'buy' the Kaiser model whole hog? I would argue that Europeans can find a way to benefit from Kaiser's many innovations in disease management and other fields without institutionalizing the model itself. As for the role of competition, I'm not sure we can find very much evidence-at least in the U.S.-that it produces the kind of positive results cited in the editorial. Kaiser is the rare example. Indeed, earlier efforts to develop integrated delivery systems (IDSs) in the U.S. created a merger mania. However, they failed disappointingly in terms of yielding improved efficiency or health outcomes. Perhaps a better place to look is Canada, where some regional health agencies-like Capital Health in Edmonton, Alberta-have successfully taken on responsibilities for the provision of integrated, outcomes-oriented health services-preventive, acute, long-term and mental health care-in addition to the public health function and the funding and regulation of the regional health system itself.
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